MAC
40
-8
PCG
43
-19
EBAY
49
-12
ES
28
12
NDAQ
52
-4
AVB
47
-2
HP
56
4
AAPL
48
8
TGNA
45
-3
CMI
58
-2
DHR
46
-3
VIX
66
11
PEG
53
-4
AMP
44
-8
TGT
58
4
AMG
52
-2
PX
50
-9
IPG
35
-4
TSCO
50
2
BK
58
-5
MAC
40
-8
PCG
43
-19
EBAY
49
-12
ES
28
12
NDAQ
52
-4
AVB
47
-2
HP
56
4
AAPL
48
8
TGNA
45
-3
CMI
58
-2
DHR
46
-3
VIX
66
11
PEG
53
-4
AMP
44
-8
TGT
58
4
AMG
52
-2
PX
50
-9
IPG
35
-4
TSCO
50
2
BK
58
-5
Financhill
Back

LENZ Therapeutics Stock Predictions

Free Stock Analysis Report: See The True Value of Any Stock

Analyze Any Stock Free
Sell
1

LENZ
LENZ Therapeutics

Last Price:
$23.20
Seasonality Move:
-6.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis: See What Your Stock is Really Worth

Analyze Any Stock Free

LENZ Therapeutics Stock Forecast

  • Over the next 52 weeks, LENZ Therapeutics has on average historically risen by 0.7% based on the past 3 years of stock performance.
  • LENZ Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is LENZ Therapeutics Stock Undervalued?
    The current LENZ Therapeutics [LENZ] share price is $23.21. The Score for LENZ is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • LENZ is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will LENZ Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, LENZ Therapeutics has on average historically risen by 0.7% based on the past 3 years of stock performance.

LENZ Therapeutics Stock Rating

Sell
1
LENZ Therapeutics (LENZ) is a Sell

Is LENZ Therapeutics overpriced?

  • LENZ Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

LENZ Therapeutics Stock Price History

Is LENZ stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LENZ is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
lenz-tx.com

52-Week Data

52-Week High:
38.93
52-Week Low:
14.42

Prediction Charts

Market Cap:
638.3M
Price in USD:
23.21
Volume:
212.3K
Beta:
0.58

Technical Analysis

SMA50:
32.11
SMA100:
27.82
SMA200:
23.42
52-Wk Change:
15.53%

Stock Predictions

  • Is LENZ Therapeutics stock public?
    Yes, LENZ Therapeutics is a publicly traded company.
  • What is the LENZ Therapeutics stock quote today?
    The LENZ Therapeutics stock price is 23.21 USD today.
  • How to buy LENZ Therapeutics stock online?
    You can buy LENZ Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-19 29.37 30.28 31.50 28.90
Dec-20 29.75 32.63 33.84 29.05
Dec-23 32.27 31.30 32.27 30.00
Dec-24 31.30 31.50 31.96 30.74
Dec-26 31.28 32.01 33.79 31.10
Dec-27 31.47 31.32 32.64 30.95
Dec-30 30.58 30.07 30.96 29.45
Dec-31 30.07 28.87 30.61 28.63
Jan-2 29.03 28.29 29.53 28.07
Jan-3 28.57 28.46 29.11 27.60
Jan-6 28.45 27.26 28.45 27.15
Jan-7 27.06 27.18 27.86 26.64
Jan-8 27.18 26.34 27.18 26.10
Jan-10 25.52 23.21 25.82 23.10

LENZ Therapeutics Earnings

LENZ Therapeutics Earnings Report: Per Share LENZ Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

LENZ Therapeutics Forecast Revenue Growth

LENZ Therapeutics Stock Analysis: Historical quarterly revenues per share for LENZ Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.50 per share.

* LENZ Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.